OMNICARE, INC. for OMNICARE INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report (this page) | Oct 20, 2015 | $20,000 | Replaced |
| 3rd Quarter - Termination | Oct 21, 2015 | $20,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare Part D reimbursement; Medicare Part D audit policy; Medicare anti-fraud, waste and abuse policy; Medicaid FFS drug reimbursement; Medicare innovative health care and delivery models; Post-acute care payment policy reform; Medicare Part D network access issues; Safe-harbor and anti-kickback policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH TERRY | — |
Pharmacy PHA
Drug Enforcement Administration rule on disposal of controlled substances in long term care facilities; Reclassification of hydrocodone-containing prescription drugs from Schedule III to Schedule II drugs; Controlled substances policy; Biosimilars policy; Hazardous drug handling policy; FDA drug compounding policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH TERRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.